THE ROLE OF INTRACAVERNOSAL VASOACTIVE AGENTS TO OVERCOME IMPOTENCE DUE TO SPINAL-CORD INJURY

被引：20

作者：

EARLE, CM ^{[1
]}

KEOGH, EJ ^{[1
]}

KER, JK ^{[1
]}

CHERRY, DJ ^{[1
]}

TULLOCH, AGS ^{[1
]}

LORD, DJ ^{[1
]}

机构：

[1] SIR CHARLES GAIRDNER HOSP,REPROD MED RES INST,VERDUN STR,NEDLANDS,WA 6009,AUSTRALIA

来源：

PARAPLEGIA | 1992年 / 30卷 / 04期

关键词：

IMPOTENCE; SPINAL CORD INJURIES; INTRACAVERNOSAL INJECTIONS; PROSTAGLANDIN-E1; PAPAVERINE;

D O I：

10.1038/sc.1992.68

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Twenty-two spinal cord injured men (mean age 35.2 years) referred because of impotence were treated with intracavernosal vasoactive agents. Papaverine 2-20 mg, papaverine 40 mg plus phentolamine 0.5 mg or prostaglandin E1 (1-20 ug) were used. Nineteen responded and were taught to self administer the medication with varying degrees of assistance from their partners. Fourteen men participated in a postal survey; 12 (86%) continued to use the drugs every 1 to 4 weeks and reported satisfaction with the method. Partner responses were positive in half of the group and when not so it influenced the patients to abandon or reduce the frequency of treatment. Counselling was essential to allay anxiety. Clinical management was not compromised and side effects were minimal. Overall we found this treatment effective, safe and worthwhile.

引用

页码：273 / 276

页数：4

共 16 条

[1]

Collins K.P., Hackler R.H., Complications of penile prostheses in the spinal cord injury population, J Urol, 140, pp. 984-985, (1988)

[2]

Brindley G.S., Cavernosal alpha-blockade: A new technique for investigating and treating erectile impotence, B J Psychiatry, 143, pp. 332-337, (1983)

[3]

Virag R., Frydman D., Legman M., Virag H., Intracavernous injection of papaverine as a diagnostic and therapeutic method in erectile failure, Angiology, 35, pp. 79-87, (1984)

[4]

Zorginiotti A.W., Lefleur R.S., Auto-injection of vasoactive drug combination for vasculogenic impotence, J Ural, 133, pp. 39-41, (1985)

[5]

Earle C.M., Keogh E.J., Wisniewski Z.S., Prostaglandin Ei therapy for impotence, comparison with papaverine, Jural, 143, pp. 57-59, (1990)

[6]

Watters G.R., Keogh E.J., Earle C.M., Experience in the management of erectile dysfunction using the intracavernosal self-injection of vasoactive drugs, J Urol, 140, pp. 1417-1419, (1988)

[7]

Momose H., Natsume O., Yamamoto M., Suemori T., Yamada K., Intracavernous injection of papaverine hydrochloride for impotence in patients with spinal cord injury, Hinyokika Kiyo, 33, 7, pp. 1065-1069, (1987)

[8]

Wyndaele J.J., De Meyer J.M., De Sy W.A., Claessens H., Intracavernous injection of vasoactive drugs, an alternative for treating impotence in spinal cord injury patients, Paraplegia, 24, 5, pp. 271-275, (1986)

[9]

Bodner D.R., Lindan R., Leffler E., Resmick M.F., The application of intracavernous injection of vasoactive medication for erection in men with spinal cord injury, J Ural, 138, pp. 310-311, (1987)

[10]

Sidi A.A., Cameron J.S., Dykstra D.D., Reinberg Y., Lange P.H., Vasoactive intracavernous pharmaco¬therapy for the treatment of erectile impotence in men with spinal cord injury, J Ural, 138, pp. 539-542, (1987)

← 1 2 →